High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus

AIDS
Deborah KonopnickiStéphane De Wit

Abstract

Worldwide, human papillomavirus (HPV) 16 and 18 represents 70% of high-risk (HR) HPV found in cervical cancer. However HIV-positive women are more frequently infected by HRHPV other than HPV 16 or 18 (OHR). We aimed to analyse the HRHPV genotype distribution in a cohort of HIV-positive women and to estimate the potential protection offered by the different HPV vaccines. HRHPV genotypes by PCR and cytology were assessed in cervical samples from 508 HIV-positive women prospectively followed in Brussels. Women characteristics were as follows: African origin (84%), median age 42 years, median CD4 T 555/μl, 89% under combined antiretroviral therapy and 73% with HIVRNA less than 20 copies/ml. HRHPV prevalence was 23% (116/508): 38% had abnormal cytology, 76% carried OHR without HPV 16 or 18 and 11% had concomitant infection by OHR and HPV 16 or 18. The most frequent HRHPV were HPV52 (19.8%), HPV18 (14.6%), HPV31/35/51/58 (12.1% each), HPV56 (9.9%) and HPV16 (9.5%). Less than 30% of women had their HRHPV genotypes included in the bivalent or quadrivalent vaccines against HRHPV 16 and 18; however, 79% had their HRHPV covered by the ninevalent vaccine against HRHPV 16/18/31/33/45/52/58. The HRHPV genotypes distribution found in these wo...Continue Reading

References

Nov 23, 1989·The New England Journal of Medicine·N ClumeckS De Wit
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Jul 17, 2003·Journal of the National Cancer Institute·Howard D StricklerRobert D Burk
Nov 23, 2006·AIDS·Gary M CliffordUNKNOWN HPV and HIV Study Group
Apr 18, 2007·British Journal of Cancer·V V SahasrabuddheG P Parham
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marc ArbynChristophe Depuydt
Feb 20, 2010·Infectious Diseases in Obstetrics and Gynecology·Andrew J DesruisseauEdith Welty
Dec 6, 2011·BMC Infectious Diseases·Nienke J VeldhuijzenJanneke H H M van de Wijgert
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Peng GuanGary M Clifford
Jul 12, 2012·British Journal of Cancer·A JaquetUNKNOWN IeDEA West Africa collaboration
Oct 10, 2012·The Journal of Infectious Diseases·Susan HaririUNKNOWN HPV-IMPACT Working Group
Nov 6, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·I HeardUNKNOWN MACH-1 Study Group
Feb 15, 2013·Journal of the International AIDS Society·Deborah KonopnickiNathan Clumeck
Jun 15, 2014·Cancer Causes & Control : CCC·Adriana C VidalCathrine Hoyo
Aug 16, 2014·The Journal of Pathology·Marc ArbynJoakim Dillner
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study

❮ Previous
Next ❯

Citations

Sep 28, 2018·Human Vaccines & Immunotherapeutics·Giovanna OrlandoElisabetta Tanzi
May 18, 2021·Frontiers in Public Health·Jacqueline Cortinhas MonteiroLuiz Fernando Almeida Machado

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
biopsy
PCR
biopsies
hysterectomy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.